The less-known face of dupilumab: its role in mesenchymal stem cells by interleukin-13 modulation.

Campanati, A; Di Vincenzo, M; Radi, G; Rizzetto, G; Carnevale, G; Marchi, S; Orciani, M; Offidani, A

Campanati, A; Di Vincenzo, M; Radi, G; Rizzetto, G; Carnevale, G; Marchi, S; Orciani, M; Offidani, A.

Afiliación

Campanati A; Dermatological Clinic, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
Di Vincenzo M; Department of Clinical and Molecular Sciences - Histology, Università Politecnica delle Marche, Ancona, Italy.
Radi G; Dermatological Clinic, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
Rizzetto G; Dermatological Clinic, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
Carnevale G; Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Marchi S; Department of Clinical and Molecular Sciences - Histology, Università Politecnica delle Marche, Ancona, Italy.
Orciani M; Department of Clinical and Molecular Sciences - Histology, Università Politecnica delle Marche, Ancona, Italy.
Offidani A; Dermatological Clinic, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.

Br J Dermatol ; 185(1): 217-219, 2021 07.

Article en En | MEDLINE | ID: mdl-33657639

Asunto(s)

Antiasmáticos; Células Madre Mesenquimatosas; Anticuerpos Monoclonales Humanizados; Interleucina-13

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antiasmáticos / Células Madre Mesenquimatosas Idioma: En Revista: Br J Dermatol Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google